Skip to main content
. 2024 Jan 2;8:2. doi: 10.1186/s41747-023-00396-z

Fig. 1.

Fig. 1

Flowchart of patient selection. 19Del 19 deletion, 21L858R 21-point mutation, BM Brain metastases, CNS Central nervous system, EGFR Epidermal growth factor receptor, MRI Magnetic resonance imaging, NSCLC Non-small cell lung cancer, WT Wild-type